Delivery Order SPE2DB20D3101-SPE2DB24FRCT0

Award Date 3/1/24
Potential Completion Date 3/4/24
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,975.00 firm-fixed-price delivery order is for the supply of BEYFORTUS 100 MG/ML SYRINGEML, a pharmaceutical product. The contract has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,036.64, is for the procurement of BEYFORTUS 100 MG/ML syringes, a medical product. The contract is a firm fixed-price type with a period of performance through February 8, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,975.00 firm-fixed-price delivery order is for the supply of BEYFORTUS 100 MG/ML SYRINGE/ML, a medical product. The award has an ultimate completion date of October 30, 2024 and was made on October 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,030.88, is for the delivery of the drug BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML. It is a firm fixed-price delivery order contract with an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,668.64, is for the provision of BEYFORTUS 100 MG/ML SYRINGEML, a medical product. The contract type is Firm Fixed Price, and the ultimate completion date is October 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of BEYFORTUS 100 MG/ML SYRINGEML. The contract has a firm fixed price of $16,149.76 and a completion date of January 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,027.52 firm fixed-price delivery order is for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of November 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,490.66 firm fixed-price delivery order is for the supply of BEYFORTUS 100 MG/ML SYRINGEML, a medical product, and has an ultimate completion date of October 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $12,381.86 and a period of performance through December 9, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BEYFORTUS 100 MG/ML SYRINGE/ML. The firm-fixed-price contract has a ceiling value of $32,869.15 and an ultimate completion date of September 26, 2024. This award is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRCT0
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $15,520.80 firm fixed-price contract is for the provision of BEYFORTUS 100 MG/ML syringes, with a period of performance through March 4, 2024. The contract is not a set-aside award.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 12:17 PM